Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?

Many broadly neutralizing antibodies (bnAbs) targeting the HIV-1 envelope glycoprotein are being assessed in clinical trials as strategies for HIV-1 prevention, treatment, and antiretroviral-free remission. BnAbs can neutralize HIV-1 and target infected cells for elimination. Concerns about HIV-1 re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Denise C., Mellors, John W., Vasan, Sandhya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311790/
https://www.ncbi.nlm.nih.gov/pubmed/34322136
http://dx.doi.org/10.3389/fimmu.2021.710044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311790/
https://www.ncbi.nlm.nih.gov/pubmed/34322136
http://dx.doi.org/10.3389/fimmu.2021.710044

Ejemplares similares